EPS Diluted from Accounting Change (Quarterly) Chart

View EPS Diluted from Accounting Change (Quarterly) for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Accounting Change (Quarterly) Benchmarks

View EPS Diluted from Accounting Change (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. --
XOMA Royalty Corp. --
Omeros Corp. --
GeoVax Labs, Inc. --
Daré Bioscience, Inc. --